There is no reliable, multi-analyst consensus for SHFS. EF Hutton analyst Michael Albanese has maintained a Buy rating with a $1.50 price target, but that single target predates the company's 1-for-12 reverse stock split and the ensuing Series B conversions, making it of limited current relevance. Separately, TipRanks' AI analyst "Spark" rates the stock Underperform with a $0.09 target, citing weak financial performance and bearish technicals. Because these two inputs cannot be aggregated into a credible consensus, the $1.00 figure used here is a fallback objective drawn from public discussion: the $1.00 Nasdaq minimum bid price the company is explicitly pursuing. It should not be read as an analyst forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
SHFS trades at roughly $0.02, having swung between about $0.012 and $0.026 in recent sessions. Reaching $1.00 would require an increase of approximately 4,900%, an extraordinary move for any stock. Notably, the company has stated it will consider another reverse stock split to restore the share price above $1.00, meaning the path to this level is more likely to be mechanical (share-count reduction) than a genuine re-rating of the business. Fundamentals are mixed: third-quarter 2026 revenue rose 6.5% to $1.95 million and loan-program income jumped 70.2%, but the company still posted a net loss of roughly $979,000 and carries a going-concern disclosure.
The most meaningful levels are regulatory rather than purely technical. The $1.00 minimum bid price is the decisive resistance the company must hold; the $0.10 level is the low-price threshold that can trigger delisting. On a split-adjusted basis, the stock has collapsed from a 52-week high near $28 to roughly $0.02, reflecting the September 30, 2026, reverse split and subsequent conversions. There is no established support base at current levels, and the overwhelming trend structure is negative. From what I see, monitoring these regulatory thresholds is key for any position in SHFS.
The $1.00 objective is tied to an explicit date: the April 19, 2027, Nasdaq compliance deadline, rather than a standard 12-month research horizon. Investors should watch the daily closing bid price relative to both $0.10 and $1.00, any announcement of a further reverse split, progress or termination of the Opifex term sheet, further Series B conversions and their dilutive effect, the Abaca court ruling, and quarterly results for evidence of sustained deposit and loan-income growth. Each of these can materially change the odds of reaching or losing the listing. I’m watching this closely as developments unfold.
For traders tracking a highly volatile name like SHFS, AI Daily Buy/Sell Signals offers an alternative lens. Tickeron's system uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. This can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual chart-watching, especially in fast-moving, low-priced securities where traditional fundamentals may lag price action.
Can SHFS reach $1.00? The answer depends on how the level is reached. As an organic, ~50-fold re-rating, it is extraordinarily unlikely given the company's losses, going-concern warning, and severe dilution. As a mechanical milestone achieved through another reverse stock split or a completed Opifex combination, it is a real and actively pursued objective — but one that carries substantial uncertainty and would not, by itself, restore shareholder value. The strongest supports are improving deposits and loan income; the principal obstacles are dilution, delisting risk, and a fragile balance sheet. With no credible analyst consensus available, investors should treat $1.00 as a regulatory threshold to monitor, not a valuation-derived forecast.
In my view, tools like AI Daily Buy/Sell Signals have become part of my regular process for staying on top of names like this. The platform’s AI-driven approach helps cut through noise in fast-moving micro caps, offering signals based on real-time technical and market data that complement traditional analysis. I find it particularly useful for setting alerts around key levels without having to watch every tick.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Moving Average Convergence Divergence (MACD) for SHFS just turned positive on October 23, 2026. Looking at past instances where SHFS's MACD turned positive, the stock continued to rise in 29 of 43 cases over the following month. The odds of a continued upward trend are 67%.
Following a +281.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where SHFS advanced for three days, in 125 of 165 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHFS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for SHFS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SHFS's P/B Ratio (0.053) is slightly lower than the industry average of (1.262). P/E Ratio (-0.027) is within average values for comparable stocks, (13.480). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.194). Dividend Yield (0.000) settles around the average of (0.035) among similar stocks. SHFS's P/S Ratio (0.063) is very low in comparison to the industry average of (3.740).
The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. SHFS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHFS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry RegionalBanks